相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeting advanced urothelial carcinoma-developing strategies
Omar Alhalabi et al.
CURRENT OPINION IN ONCOLOGY (2019)
Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Jason A. Efstathiou et al.
EUROPEAN UROLOGY (2019)
FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
Alvaro Quintanal-Villalonga et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts
Gottfrid Sjodahl et al.
JOURNAL OF PATHOLOGY (2019)
CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer
Asim Pervaiz et al.
CELLULAR ONCOLOGY (2019)
Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma - A marker of malignancy and possible therapeutic target
F. Millanta et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
Shingo Maeda et al.
BMC CANCER (2018)
Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody
Tadanobu Nagaya et al.
Oncotarget (2018)
Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer
Deepika Dhawan et al.
PLOS GENETICS (2018)
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma
Nicholas M. Szigetvari et al.
Oncotarget (2018)
Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features
Wei Li et al.
MEDICAL SCIENCE MONITOR (2018)
Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies
Breann C. Sommer et al.
BLADDER CANCER (2018)
Skeletal Metastasis of Canine Urothelial Carcinoma: Pathologic and Computed Tomographic Features
V. A. Charney et al.
VETERINARY PATHOLOGY (2017)
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
Roland Seiler et al.
EUROPEAN UROLOGY (2017)
Urothelial Bladder Cancer: An Update on Molecular Pathology with Clinical Implications
Simone Bertz et al.
EUROPEAN UROLOGY SUPPLEMENTS (2017)
Cross-species analysis of the canine and human bladder cancer transcriptome and exome
Stephen A. Ramsey et al.
GENES CHROMOSOMES & CANCER (2017)
Gene expression profiling in bladder cancer identifies potential therapeutic targets
Syed A. Hussain et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification
Gottfrid Sjodahl et al.
JOURNAL OF PATHOLOGY (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis
Dong-Qing Zhang et al.
ONCOLOGY LETTERS (2017)
Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs
Christopher M. Fulkerson et al.
INTERNATIONAL JOURNAL OF GENOMICS (2017)
Integrating personalized gene expression profiles into predictive disease-associated gene pools
Joerg Menche et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Niels Halama et al.
CANCER CELL (2016)
Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
Pia M. Challita-Eid et al.
CANCER RESEARCH (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data
Ricardo de Matos Simoes et al.
BMC SYSTEMS BIOLOGY (2015)
Canine urothelial carcinoma: genomically aberrant and comparatively relevant
S. G. Shapiro et al.
CHROMOSOME RESEARCH (2015)
Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer-Evidence for a Relevant Model System and Urine-Based Diagnostic Test
Brennan Decker et al.
MOLECULAR CANCER RESEARCH (2015)
Management of transitional cell carcinoma of the urinary bladder in dogs: A review
Christopher M. Fulkerson et al.
VETERINARY JOURNAL (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
BRAF Mutations in Canine Cancers
Hiroyuki Mochizuki et al.
PLOS ONE (2015)
Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer
Deepika Dhawan et al.
PLOS ONE (2015)
Biological determinants of bladder cancer gene expression subtypes
Mattias Aine et al.
SCIENTIFIC REPORTS (2015)
Causal analysis approaches in Ingenuity Pathway Analysis
Andreas Kraemer et al.
BIOINFORMATICS (2014)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma
Markus Riester et al.
CLINICAL CANCER RESEARCH (2014)
Urinary Bladder Cancer in Dogs, a Naturally Occurring Model for Cancer Biology and Drug Development
Deborah W. Knapp et al.
ILAR JOURNAL (2014)
The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS Mutations
Chan Kwon Jung et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Jeffrey S. Damrauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Targeting Folate Receptors to Treat Invasive Urinary Bladder Cancer
Deepika Dhawan et al.
CANCER RESEARCH (2013)
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA
Virginia Lopez et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Pan-cancer patterns of somatic copy number alteration
Travis I. Zack et al.
NATURE GENETICS (2013)
Tumor adaptation and resistance to RAF inhibitors
Piro Lito et al.
NATURE MEDICINE (2013)
CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
Marco Velasco-Velazquez et al.
CANCER RESEARCH (2012)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
Subcutaneous 5-Azacitidine Treatment of Naturally Occurring Canine Urothelial Carcinoma: A Novel Epigenetic Approach to Human Urothelial Carcinoma Drug Development
Noah M. Hahn et al.
JOURNAL OF UROLOGY (2012)
Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples
Gunter P. Wagner et al.
THEORY IN BIOSCIENCES (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
R. Matsuda et al.
BRITISH JOURNAL OF CANCER (2011)
RGS22, a novel cancer/testis antigen, inhibits epithelial cell invasion and metastasis
Yanqiu Hu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Mutational analysis of the BRAF gene in transitional cell carcinoma of the bladder
Ioannis Boulalas et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2009)
Genetic aberrations in prostate cancer by microarray analysis
Outi R. Saramaki et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
The human genome browser at UCSC
WJ Kent et al.
GENOME RESEARCH (2002)
Naturally-occurring canine transitional cell carcinoma of the urinary bladder - A relevant model of human invasive bladder cancer
DW Knapp et al.
UROLOGIC ONCOLOGY (2000)